AV-COVID-19

BIOLOGICAL5 trials

Sponsors

Aivita Biomedical, Inc., Indonesia-MoH, Ina-Respond

Conditions

COVID-19

Phase 1

Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults

WithdrawnNCT04386252

Aivita Biomedical, Inc.COVID-19

Start: 2023-01-31End: 2024-01-31Updated: 2023-05-03

Dendritic Cell Vaccine to Prevent COVID-19

Indonesia-MoHCOVID-19

Start: 2020-12-07End: 2022-01-31Target: 27Updated: 2020-12-29

Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection

CompletedNCT04690387

Aivita Biomedical, Inc.COVID-19

Start: 2020-12-07End: 2021-01-15Updated: 2021-12-16

Dendritic Cell Vaccine to Prevent COVID-19

WithdrawnNCT07501208

Ina-RespondCOVID-19

Start: 2020-12-07End: 2022-01-31Updated: 2026-03-30

Phase 2

Preventive Dendritic Cell Vaccine, AV-COVID-19, in Subjects Not Actively Infected With COVID-19

CompletedNCT05007496

Aivita Biomedical, Inc.COVID-19

Start: 2021-04-14End: 2021-05-31Updated: 2021-08-20